The Trump administration is closing a loophole that drugmakers could use to avoid negotiations when they add active ingredients to drugs. It's also codifying regulations.

If you’re considering taking a GLP-1 (glucagon-like peptide-1) receptor agonist for weight loss, here’s what to know about the long-term benefits and risks, along with insights from physicians. GLP-1 ...

GLP-1 microdosing is when people take smaller doses of GLP-1 drugs than are typically prescribed or FDA-recommended, often ...

Novo Nordisk NVO has received another commercial boost as the Medicare GLP-1 Bridge program officially went live on July 1, ...

A new oral insulin embedded in sugar-free chocolate uses nano-carriers to target the liver, cutting hypoglycemia risk. The ...

Tennessee's lethal injection protocol adopted a year and a half ago appears to include reduced training in IV placement. That ...

A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years, according to ...

An Indiana prison is being built to accommodate firing squad executions as the state works to pass a law allowing for that execution method, which legal experts say is further compounded by federal ...

Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental ...

The state will still allow lethal injection for death-row prisoners if it's not possible to use the firing squad.